The Valley Desk

Clinical trial reportNature medicinePublished

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, University of Pennsylvania, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Nature medicine
Published
Subject terms
Humans; Adenoviridae; Carcinoma in Situ; BCG Vaccine; Combined Modality Therapy; Aged; Aged, 80 and over; Middle Aged; Female; Male; Oncolytic Virotherapy; Oncolytic Viruses
PubMed ID
38844794
Added to directory
Source checked

Report a correction or request removal